Acelyrin, Inc. (SLRN) Tops Q2 EPS by 22c

Acelyrin, Inc. (NASDAQ: SLRN) reported Q2 EPS of ($0.86), $0.22 better than the analyst estimate of ($1.08).

For earnings history and earnings-related data on Acelyrin, Inc. (SLRN) click here.

You May Also Be Interested In

• Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
• Goldman Sachs Downgrades Shurgard Self Storage SA (SHUR:BB) to Neutral
• Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)